Literature DB >> 28870504

The oxidized phospholipid POVPC impairs endothelial function and vasodilation via uncoupling endothelial nitric oxide synthase.

Feng-Xia Yan1, Hua-Ming Li1, Shang-Xuan Li2, Shi-Hui He1, Wei-Ping Dai1, Yan Li1, Tian-Tian Wang1, Mao-Mao Shi1, Hao-Xiang Yuan1, Zhe Xu3, Jia-Guo Zhou4, Da-Sheng Ning1, Zhi-Wei Mo1, Zhi-Jun Ou5, Jing-Song Ou6.   

Abstract

Endothelial dysfunction is an early stage of atherosclerosis. We recently have shown that 25-hydroxycholesterol found in atherosclerotic lesions could impair endothelial function and vasodilation by uncoupling and inhibiting endothelial nitric oxide synthase (eNOS). 1-Palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine (POVPC), the oxidation product of oxidized low-density lipoprotein, is another proinflammatory lipid and has also been found in atherosclerotic lesions. However, whether POVPC promotes atherosclerosis like 25-hydroxycholesterol remains unclear. The purpose of this study was to explore the effects of POVPC on endothelial function and vasodilation. Human umbilical vein endothelial cells (HUVECs) were incubated with POVPC. Endothelial cell proliferation, migration and tube formation were measured. Nitric oxide (NO) production and superoxide anion generation (O2-) were determined. The expression and phosphorylation of endothelial nitric oxide synthase (eNOS), AKT, PKC-βII and P70S6K as well as the association of eNOS and heat shock protein 90 (HSP90) were detected by immunoblotting and immunoprecipitation. Endothelial cell apoptosis was monitored by TUNEL staining. The expression of Bcl-2, Bax, and Cleaved Caspase 3 were detected by immunoblotting. Finally, aortic ring from C57BL6 mice were isolated and treated with POVPC and the endothelium-dependent vasodilation was evaluated. POVPC significantly inhibited HUVECs proliferation, migration, tube formation, decreased NO production but increased O2- generation. POVPC inhibited the phosphorylation of Akt and eNOS at Ser1177, increased activation of PKC-βII, P70S6K and the phosphorylation of eNOS at Thr495, reduced the association of HSP90 with eNOS. Meanwhile, POVPC induced endothelial cell apoptosis by inhibiting Bcl-2 expression, increasing Bax and cleaved caspase-3 expressions as well as caspase-3 activity and impaired endothelium-dependent vasodilation. These data demonstrated that POVPC impaired endothelial function by uncoupling and inhibiting eNOS as well as by inducing endothelial cell apoptosis. Therefore, POVPC may play an important role in the development of atherosclerosis and may be considered as a potential therapeutic target for atherosclerosis.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  1-Palmitoyl-2-(5-oxovaleroyl)-sn-glycero-3-phosphocholine; Apoptosis; Atherosclerosis; Endothelial function; Vasodilation

Mesh:

Substances:

Year:  2017        PMID: 28870504     DOI: 10.1016/j.yjmcc.2017.08.016

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  9 in total

1.  [Effect of atorvastatin on LOX-1 and eNOS expression in collateral vessels of hypercholesterolemic rats].

Authors:  Tang Yinjuan; Wang Jianjun; Guan Yinglu; Cai Weijun; Tang Weijun; Luo Mingying
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-11-30

Review 2.  Mechanisms of Oxidized LDL-Mediated Endothelial Dysfunction and Its Consequences for the Development of Atherosclerosis.

Authors:  Hui Jiang; Yongwen Zhou; Seyed M Nabavi; Amirhossein Sahebkar; Peter J Little; Suowen Xu; Jianping Weng; Jianjun Ge
Journal:  Front Cardiovasc Med       Date:  2022-06-01

3.  The Levels of Oxidized Phospholipids in High-Density Lipoprotein During the Course of Sepsis and Their Prognostic Value.

Authors:  Zhaohong Li; Zengtao Luo; Xiaoqian Shi; Baosen Pang; Yingmin Ma; Jiawei Jin
Journal:  Front Immunol       Date:  2022-05-03       Impact factor: 8.786

Review 4.  Phospholipid Membrane Transport and Associated Diseases.

Authors:  Raúl Ventura; Inma Martínez-Ruiz; María Isabel Hernández-Alvarez
Journal:  Biomedicines       Date:  2022-05-23

Review 5.  Application of targeted therapy strategies with nanomedicine delivery for atherosclerosis.

Authors:  Le-Chun Ou; Shan Zhong; Jing-Song Ou; Jin-Wei Tian
Journal:  Acta Pharmacol Sin       Date:  2020-05-26       Impact factor: 6.150

6.  Blocking mitochondrial cyclophilin D ameliorates TSH-impaired defensive barrier of artery.

Authors:  Xiaojing Liu; Heng Du; Qiang Chai; Qing Jia; Lu Liu; Meng Zhao; Jun Li; Hui Tang; Wenbin Chen; Lifang Zhao; Li Fang; Ling Gao; Jiajun Zhao
Journal:  Redox Biol       Date:  2018-01-09       Impact factor: 11.799

7.  Dihydromyricetin protects HUVECs of oxidative damage induced by sodium nitroprusside through activating PI3K/Akt/FoxO3a signalling pathway.

Authors:  Xiaoying Zhang; Lifang Wang; Lizhi Peng; Xiaoying Tian; Xiaoyuan Qiu; Huan Cao; Qiaohong Yang; Rifang Liao; Fengxia Yan
Journal:  J Cell Mol Med       Date:  2019-05-21       Impact factor: 5.310

8.  Heat shock protein 90 is downregulated in calcific aortic valve disease.

Authors:  Jonna Weisell; Pauli Ohukainen; Juha Näpänkangas; Steffen Ohlmeier; Ulrich Bergmann; Tuomas Peltonen; Panu Taskinen; Heikki Ruskoaho; Jaana Rysä
Journal:  BMC Cardiovasc Disord       Date:  2019-12-19       Impact factor: 2.298

Review 9.  Evidence for the Benefits of Melatonin in Cardiovascular Disease.

Authors:  Mohammad Tobeiha; Ameneh Jafari; Sara Fadaei; Seyed Mohammad Ali Mirazimi; Fatemeh Dashti; Atefeh Amiri; Haroon Khan; Zatollah Asemi; Russel J Reiter; Michael R Hamblin; Hamed Mirzaei
Journal:  Front Cardiovasc Med       Date:  2022-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.